Consolidated net sales for the fiscal year ending January 2026 were \u00a5241,236 million (1.7% increase YoY), operating income was \u00a54,163 million (13.1% decrease YoY), and net loss attributable to owners of parent was \u00a530,322 million.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"2590","jir_company_name":"DyDo Group Holdings, Inc.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-03-04","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/03\/2590-20260304-01.pdf","jir_short_summary":"Consolidated net sales for the fiscal year ending January 2026 were \u00a5241,236 million (1.7% increase YoY), operating income was \u00a54,163 million (13.1% decrease YoY), and net loss attributable to owners of parent was \u00a530,322 million.","jir_summary":"### Summary of Business Results\nConsolidated net sales for the fiscal year ending January 2026 were \u00a5241,236 million (1.7% increase YoY). Domestic beverage operations experienced a decline in sales revenue due to decreased shipping volume, while overseas beverage operations, mainly in Turkey, achieved increased sales despite high inflation through price revisions and advertising investments. Operating income was \u00a54,163 million (13.1% decrease YoY) due to lower sales in domestic beverage operations and rising costs. Ordinary income declined to \u00a51,467 million (51.5% decrease YoY), and net loss attributable to owners of parent was \u00a530,322 million, primarily due to impairment losses related to vending machine assets in the domestic beverage segment.\n\n### Financial Position and Cash Flow Status\nTotal assets amounted to \u00a5162.812 billion (a decrease of \u00a522.434 billion YoY), mainly reflecting a reduction in fixed assets from impairment losses in the domestic beverage segment. Net assets were \u00a564.895 billion (a decrease of \u00a528.611 billion YoY). Cash flow from operating activities secured a positive balance of \u00a511.49 billion, while cash flow from financing activities was positive \u00a5300 million. Net cash totaled \u00a511.394 billion, declining \u00a53.794 billion compared to the previous fiscal year.\n\n### Segment Performance\nDomestic beverage operations recorded net sales of \u00a5142.651 billion (3.3% decrease YoY) and turned to a segment loss of \u00a52.284 billion. Overseas beverage operations performed well with net sales of \u00a565.341 billion (16.1% increase YoY) and segment profit of \u00a57.547 billion (48.5% increase YoY). Pharmaceutical-related operations posted net sales of \u00a513.435 billion (2.4% increase YoY) and segment profit of \u00a5829 million (198.8% increase YoY). Food operations had net sales of \u00a519.570 billion (5.2% decrease YoY) and segment profit of \u00a5487 million (57.9% decrease YoY). Rare disease pharmaceutical operations recorded net sales of \u00a5606 million (\u00a580 million in the prior year) and reduced segment loss to \u00a5321 million.\n\n### Outlook\nThe fiscal year ending January 2027 marks the final year of the 'Medium-Term Management Plan 2026,' with projected consolidated net sales of \u00a5246.8 billion (2.3% increase YoY), operating income of \u00a510.5 billion (152.2% increase YoY), ordinary income of \u00a58.4 billion (472.5% increase YoY), and net income attributable to owners of parent of \u00a55.0 billion. Priority will be given to restoring profitability in the domestic beverage segment through vending machine network renewal and cost reform, while driving growth via the overseas beverage segment.","jir_financial_highlights":"Net Sales: \u00a5241,236 million (1.7% increase YoY)\nOperating Income: \u00a54,163 million (13.1% decrease YoY)\nOrdinary Income: \u00a51,467 million (51.5% decrease YoY)\nNet Income Attributable to Owners of Parent: \u25b3\u00a530,322 million (Turned to loss YoY)\nNumber of Shares Outstanding: 33,137,000 shares (Unknown)\nNet Income Per Share: \u25b3\u00a5957.83 (Turned to loss YoY)\nDividend (Annual): \u00a530 (Decreased YoY (\u00a540 \u2192 \u00a530))","jir_category":"","jir_hashtags":"#DyDoGroupHoldings, #FinancialSummary, #JapaneseStocks","jir_key_figures":"Consolidated Net Sales: \u00a5241,236 million (1.7% increase YoY)\nNet Loss Attributable to Owners of Parent: \u00a530,322 million (previous year profit of \u00a53,804 million)\nOperating Income: \u00a54,163 million (13.1% decrease YoY)","jir_meta_title":"DyDo Group Holdings Financial Summary for Fiscal Year Ending January 2026: Net Sales \u00a5241.2 Billion, Net Loss \u00a530.3 Billion","jir_meta_description":"DyDo Group Holdings, Inc. announces its financial summary for the fiscal year ending January 2026. Consolidated net sales were \u00a5241,236 million (1.7% increase YoY), with a net loss attributable to owners of parent of \u00a530,322 million. Forecast for fiscal year ending January 2027 includes consolidated operating income of \u00a510.5 billion.","jir_og_title":"DyDo Group Holdings Announces Financial Summary for Fiscal Year Ending January 2026","jir_og_description":"Announced consolidated performance for fiscal year ending January 2026. Net sales increased 1.7% YoY to \u00a5241,236 million; net loss was \u00a530,322 million.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Consolidated Net Sales Trend (Million Yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Fiscal Year Ending January 2025\\\",\\\"Fiscal Year Ending January 2026\\\",\\\"Forecast Fiscal Year Ending January 2027\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Sales\\\",\\\"data\\\":[237189,241236,246800],\\\"borderColor\\\":\\\"#3e95cd\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"display\\\":true}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Consolidated Operating Income Trend (Million Yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Fiscal Year Ending January 2025\\\",\\\"Fiscal Year Ending January 2026\\\",\\\"Forecast Fiscal Year Ending January 2027\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Income\\\",\\\"data\\\":[4789,4163,10500],\\\"borderColor\\\":\\\"#8e5ea2\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"display\\\":true}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"net_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Net Income Attributable to Owners of Parent Trend (Million Yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Fiscal Year Ending January 2025\\\",\\\"Fiscal Year Ending January 2026\\\",\\\"Forecast Fiscal Year Ending January 2027\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Income\\\",\\\"data\\\":[3804,-30322,5000],\\\"borderColor\\\":\\\"#3cba9f\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"display\\\":true}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":false}}}}\"}, {\"jir_chart_id\": \"segment_revenue_breakdown\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Segment Net Sales Breakdown (Fiscal Year Ending January 2026, Million Yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Domestic Beverage Business\\\",\\\"Overseas Beverage Business\\\",\\\"Pharmaceutical-related Business\\\",\\\"Food Business\\\",\\\"Rare Disease Pharmaceuticals Business\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Sales\\\",\\\"data\\\":[142651,65341,13435,19570,606],\\\"backgroundColor\\\":[\\\"#3e95cd\\\",\\\"#8e5ea2\\\",\\\"#3cba9f\\\",\\\"#e8c3b9\\\",\\\"#c45850\\\"]}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"display\\\":false}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"segment_profit_breakdown\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Segment Operating Income Breakdown (Fiscal Year Ending January 2026, Million Yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Domestic Beverage Business\\\",\\\"Overseas Beverage Business\\\",\\\"Pharmaceutical-related Business\\\",\\\"Food Business\\\",\\\"Rare Disease Pharmaceuticals Business\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Income\\\",\\\"data\\\":[-2284,7547,829,487,-321],\\\"backgroundColor\\\":[\\\"#ff6384\\\",\\\"#36a2eb\\\",\\\"#cc65fe\\\",\\\"#ffce56\\\",\\\"#ff9f40\\\"]}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"display\\\":false}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":false}}}}\"}]","ir_related_company":16794,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-33145","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n